story of the week
Lenvatinib, Everolimus, and the Combination for Metastatic Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lenvatinib, Everolimus, and the Combination in Patients With Metastatic Renal Cell Carcinoma: A Randomised, Phase 2, Open-Label, Multicentre Trial
Lancet Oncol 2015 Oct 15;[EPub Ahead of Print], RJ Motzer, TE Hutson, H Glen, MD Michaelson, A Molina, T Eisen, J Jassem, J Zolnierek, JP Maroto, B Mellado, B Melichar, J Tomasek, A Kremer, HJ Kim, K Wood, C Dutcus, J LarkinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.